Product NDC: | 0555-0727 |
Proprietary Name: | Estropipate |
Non Proprietary Name: | Estropipate |
Active Ingredient(s): | .75 mg/1 & nbsp; Estropipate |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0555-0727 |
Labeler Name: | Barr Laboratories Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA040135 |
Marketing Category: | ANDA |
Start Marketing Date: | 19980123 |
Package NDC: | 0555-0727-02 |
Package Description: | 100 TABLET in 1 BOTTLE (0555-0727-02) |
NDC Code | 0555-0727-02 |
Proprietary Name | Estropipate |
Package Description | 100 TABLET in 1 BOTTLE (0555-0727-02) |
Product NDC | 0555-0727 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Estropipate |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 19980123 |
Marketing Category Name | ANDA |
Labeler Name | Barr Laboratories Inc. |
Substance Name | ESTROPIPATE |
Strength Number | .75 |
Strength Unit | mg/1 |
Pharmaceutical Classes |